GR3030545T3 - Use of L-carnitine and its derivatives for reducing the toxic effects of cyclosporin-A and others immunosuppressants - Google Patents
Use of L-carnitine and its derivatives for reducing the toxic effects of cyclosporin-A and others immunosuppressantsInfo
- Publication number
- GR3030545T3 GR3030545T3 GR990401622T GR990401622T GR3030545T3 GR 3030545 T3 GR3030545 T3 GR 3030545T3 GR 990401622 T GR990401622 T GR 990401622T GR 990401622 T GR990401622 T GR 990401622T GR 3030545 T3 GR3030545 T3 GR 3030545T3
- Authority
- GR
- Greece
- Prior art keywords
- carnitine
- cyclosporin
- immunosuppressants
- derivatives
- reducing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
- C07C239/08—Hydroxylamino compounds or their ethers or esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/30—Preparation of optical isomers
- C07C227/34—Preparation of optical isomers by separation of optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT95RM000037A IT1277147B1 (it) | 1995-01-20 | 1995-01-20 | Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi. |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3030545T3 true GR3030545T3 (en) | 1999-10-29 |
Family
ID=11402949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR990401622T GR3030545T3 (en) | 1995-01-20 | 1999-06-16 | Use of L-carnitine and its derivatives for reducing the toxic effects of cyclosporin-A and others immunosuppressants |
Country Status (13)
Country | Link |
---|---|
US (2) | US5955424A (el) |
EP (1) | EP0722724B1 (el) |
JP (1) | JPH08231390A (el) |
KR (1) | KR100443730B1 (el) |
AT (1) | ATE177946T1 (el) |
CA (1) | CA2167456A1 (el) |
DE (1) | DE69508551T2 (el) |
DK (1) | DK0722724T3 (el) |
ES (1) | ES2130509T3 (el) |
GR (1) | GR3030545T3 (el) |
IT (1) | IT1277147B1 (el) |
TW (1) | TW445145B (el) |
ZA (1) | ZA96431B (el) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA65587C2 (en) * | 1997-10-09 | 2004-04-15 | Baker Norton Pharma | Method for preventing nephrotoxicity induced by cyclosporins or tacrolimus |
IT1306179B1 (it) | 1999-07-28 | 2001-05-30 | Sigma Tau Healthscience Spa | Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale. |
IT1316998B1 (it) * | 2000-03-02 | 2003-05-26 | Sigma Tau Healthscience Spa | Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori. |
DE60111858T2 (de) * | 2000-10-12 | 2006-04-20 | Pharma Mar, S.A., Tres Cantos | BEHANDLUNG VON KREBSERKRANKUNGEN mit APLIDIN IN KOMBINATION MIT CARNITIN ODER ACETYLCARNITIN |
ITRM20010293A1 (it) * | 2001-05-29 | 2002-11-29 | Sigma Tau Ind Farmaceuti | Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore. |
US20050232911A1 (en) * | 2004-04-19 | 2005-10-20 | Schreiber Brian D | Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid |
US20070087975A1 (en) * | 2005-10-17 | 2007-04-19 | Sigma-Tau Industrie Farmaceutiche Riunite Spa | Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients |
CN102038671B (zh) * | 2010-06-29 | 2012-07-04 | 辽宁思百得医药科技有限公司 | 包含左卡尼汀和羟苯磺酸盐的药物组合物 |
KR101760510B1 (ko) | 2014-12-18 | 2017-07-21 | 가톨릭대학교 산학협력단 | 메트포민을 포함하는 면역억제제로 인한 신장 독성 완화용 조성물 및 이를 포함하는 면역질환 예방 또는 치료용 조성물 |
WO2016099214A1 (ko) * | 2014-12-18 | 2016-06-23 | 가톨릭대학교 산학협력단 | 메트포민을 포함하는 면역억제제로 인한 신장 독성 완화용 조성물 및 이를 포함하는 면역질환 예방 또는 치료용 조성물 |
IT201900007446A1 (it) * | 2019-05-29 | 2020-11-29 | Giuseppe Castellano | Composizione comprendente citrato e carnitina in grado di attivare la produzione della proteina klotho |
CN115469026B (zh) * | 2022-07-14 | 2023-10-20 | 中日友好医院(中日友好临床医学研究所) | 用于检测环孢素a肾毒性相关标志物的检测试剂、试剂盒及其用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1195852B (it) * | 1986-07-04 | 1988-10-27 | Sigma Tau Ind Farmaceuti | Impiego di l-carnitina nel trattamento degli effetti tossici indotti dall'inalazione di alotano e di altri anestitici generali alogenati |
JPH01213258A (ja) * | 1988-02-23 | 1989-08-28 | Kyowa Hakko Kogyo Co Ltd | カルニチンおよびカルニチンアミドの精製法 |
-
1995
- 1995-01-20 IT IT95RM000037A patent/IT1277147B1/it active IP Right Grant
- 1995-12-22 AT AT95120394T patent/ATE177946T1/de not_active IP Right Cessation
- 1995-12-22 ES ES95120394T patent/ES2130509T3/es not_active Expired - Lifetime
- 1995-12-22 DE DE69508551T patent/DE69508551T2/de not_active Expired - Fee Related
- 1995-12-22 DK DK95120394T patent/DK0722724T3/da active
- 1995-12-22 EP EP95120394A patent/EP0722724B1/en not_active Expired - Lifetime
- 1995-12-26 TW TW084113879A patent/TW445145B/zh not_active IP Right Cessation
-
1996
- 1996-01-03 US US08/580,993 patent/US5955424A/en not_active Expired - Fee Related
- 1996-01-17 CA CA002167456A patent/CA2167456A1/en not_active Abandoned
- 1996-01-19 KR KR1019960001086A patent/KR100443730B1/ko not_active IP Right Cessation
- 1996-01-19 ZA ZA96431A patent/ZA96431B/xx unknown
- 1996-01-22 JP JP8008347A patent/JPH08231390A/ja active Pending
-
1997
- 1997-09-08 US US08/925,485 patent/US5958941A/en not_active Expired - Fee Related
-
1999
- 1999-06-16 GR GR990401622T patent/GR3030545T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0722724B1 (en) | 1999-03-24 |
EP0722724A1 (en) | 1996-07-24 |
ZA96431B (en) | 1996-08-08 |
JPH08231390A (ja) | 1996-09-10 |
US5955424A (en) | 1999-09-21 |
DE69508551T2 (de) | 1999-09-02 |
ITRM950037A0 (it) | 1995-01-20 |
CA2167456A1 (en) | 1996-07-21 |
ATE177946T1 (de) | 1999-04-15 |
TW445145B (en) | 2001-07-11 |
ES2130509T3 (es) | 1999-07-01 |
KR100443730B1 (ko) | 2004-10-14 |
ITRM950037A1 (it) | 1996-07-20 |
KR960029314A (ko) | 1996-08-17 |
IT1277147B1 (it) | 1997-11-04 |
DE69508551D1 (de) | 1999-04-29 |
US5958941A (en) | 1999-09-28 |
DK0722724T3 (da) | 1999-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3030545T3 (en) | Use of L-carnitine and its derivatives for reducing the toxic effects of cyclosporin-A and others immunosuppressants | |
MX9701342A (es) | Formulacion cosolvente de tirilazad para administracion parenteral. | |
CA2235375A1 (en) | Production of analgesic synergy by co-administration of sub-analgesic doses of a .mu. opioid agonist and a .kappa.-2 opioid agonist | |
CA2183655A1 (en) | 4-polycyclic amino-substituted quinazoline derivatives | |
EP1466606A3 (en) | Use of inosine for the manufacture of a medicament for stimulating axonal outgrowth of central nervous system neurons | |
MY125662A (en) | Pharmaceutical formulations containing darifenacin | |
CA2209001A1 (en) | Hydrophobic taxane derivatives | |
MX9701013A (es) | Formulaciones oftalmicos topicas que contienen derivador de doxepina para tratamiento de enfermedades oculares alergicas. | |
IL109615A (en) | Cyclic polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
EP0630898A4 (en) | MEDICINE FOR THROMBOZYTOPENIA. | |
IL123551A0 (en) | Tricyclic erythromycin derivatives | |
CA2053826A1 (en) | Pharmaceutical compositions active in the therapy of neurological affections in aids patients | |
BG103372A (en) | PHARMACEUTICAL COMPOSITION INCLUDING AN ANTI-Xa- ACTIVITY BELONGING COMPOUND AND AN ANTAGONIST COMPOUND OF THROMBOCYTE AGGREGATION | |
EP0485636A4 (en) | Indole derivative | |
EP0620004A4 (en) | MEDICAL COMPOSITION. | |
EP0522173A4 (en) | 4-desoxy-4-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof | |
UA29435C2 (uk) | Похідні 3бета-алкенілпенаму та їх фармацевтично прийнятні солі | |
ZA9110037B (en) | The use of acetyl l-carnitine in the therapeutic treatment of coma and pharmacological compositions useful in such treatment | |
IL117971A (en) | Pharmaceutical compositions containing olanzapine for treating dyskinesias | |
CA2179733A1 (en) | Anticonvulsant pseudofructopyranose sulfamates | |
ZA892188B (en) | Peptide derivatives | |
CA2190837A1 (en) | Transdermal delivery of anti-epileptic drugs | |
EP0855398A4 (en) | SESQUITERPEN DERIVATIVES WITH ANTIVITAL ACTIVITY | |
AU6970394A (en) | Desoxyazaphospholipid derivatives having inhibiting activity on phospholipase a2 | |
GB9420748D0 (en) | 1,5 benzodiazepine derivatives |